Safety and Tolerability of RNS60 Given by IV to Healthy Subjects

Summary

The objective of this study is to evaluate the safety and tolerability of RNS60 administered intravenously to healthy subjects. 12 subjects will receive RNS60 or placebo at three escalating rates for 48 hours for each rate.

Timeline

Start

2011-07

Primary completion

2011-09

Completion

2011-09

Drugs

Indications